Indo US Bio-Tech Ltd (INDOUS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002989, "name": "Indo US Bio-Tech", "stock_name": "Indo US Bio-Tech", "full_name": "Indo US Bio-Tech Ltd", "name_url": "stocks-analysis/indo-us-bio-tech", "exchange": 1, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "119.56", "chg": -5.66, "chgp": "-4.52%", "dir": -1, "prev_price": "125.22", "mcapval": "255.00 Cr", "mcap": "Micro Cap", "scripcode": 541304, "symbol": "INDOUS", "ind_name": "Other Agricultural Products", "ind_code": 61, "indexname": "", "isin": "INE250Z01010", "curr_date": "Feb 01", "curr_time": "", "bse_nse_vol": "7.55 k", "exc_status": "Active", "traded_date": "Feb 01, 2026", "traded_date_str": "2026 02 01", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indo-us-bio-tech-1002989-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Indo US Bio-Tech Gains 3.32%: 5 Key Factors Driving the Weekly Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-gains-332-5-key-factors-driving-the-weekly-move-3803264", "imagepath": "", "date": "2026-01-24 12:05:00", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 19:</strong> Stock hits 52-week low at Rs.110.20 amid market pressure</p>\n <p><strong>Jan 20:</strong> New 52-week low at Rs.107.25; Mojo Grade downgraded to Sell</p>\n <p><strong>Jan 21:</strong> Further 52-week low at Rs.105.40 despite intraday gains</p>\n <p><strong>Jan 22:</strong> Reports sharp quarterly financial decline; stock rebounds +3.03%</p>\n <p><strong>Jan 23:</strong> Stock closes week at Rs.118.30, up 2.42% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">..." }, { "title": "Indo US Bio-Tech Ltd Reports Sharp Decline in Quarterly Financials Amid Negative Trend Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-ltd-reports-sharp-decline-in-quarterly-financials-amid-negative-trend-shift-3799444", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndoUSBioTechLt_fintrenddot_3799444.png", "date": "2026-01-22 08:00:17", "description": "Indo US Bio-Tech Ltd has reported a significant downturn in its latest quarterly financial performance, marking a shift from a previously flat to a negative financial trend. The company’s December 2025 quarter results reveal contraction across key metrics including revenue, profitability, and earnings per share, signalling challenges ahead for this player in the Other Agricultural Products sector." }, { "title": "Indo US Bio-Tech Ltd Falls to 52-Week Low Amidst Continued Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-ltd-falls-to-52-week-low-amidst-continued-underperformance-3796414", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndoUSBioTechLt_priceRelatedfactors_3796414.png", "date": "2026-01-20 11:46:35", "description": "Indo US Bio-Tech Ltd’s stock declined sharply to a new 52-week low of Rs.109.7 today, marking a significant drop amid a challenging market environment and subdued financial performance. The stock’s fall contrasts with the broader market’s mixed movements, highlighting company-specific pressures." }, { "title": "Indo US Bio-Tech Downgraded to Sell Amid Technical Weakness and Flat Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-downgraded-to-sell-amid-technical-weakness-and-flat-financials-3795521", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndoUSBioTechLt_mojoScore_3795521.png", "date": "2026-01-20 08:30:06", "description": "Indo US Bio-Tech Ltd, a player in the Other Agricultural Products sector, has seen its investment rating downgraded from Hold to Sell as of 19 Jan 2026. This shift reflects deteriorating technical indicators, flat recent financial performance, and a challenging near-term outlook despite some strong long-term fundamentals. The company’s Mojo Score has declined to 47.0, signalling caution for investors amid a 3.8% drop in share price on the downgrade day." }, { "title": "Indo US Bio-Tech Ltd Falls to 52-Week Low Amidst Continued Market Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-ltd-falls-to-52-week-low-amidst-continued-market-pressure-3794776", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndoUSBioTechLt_priceRelatedfactors_3794776.png", "date": "2026-01-19 15:41:07", "description": "Indo US Bio-Tech Ltd, a player in the Other Agricultural Products sector, touched a fresh 52-week low of Rs.110.15 today, marking a significant decline amid broader market weakness and sector underperformance. The stock’s fall reflects ongoing pressures despite some underlying financial strengths." }, { "title": "When is the next results date for Indo US Bio-Tech Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-indo-us-bio-tech-ltd-3790617", "imagepath": "", "date": "2026-01-13 23:16:11", "description": "The next results date for Indo US Bio-Tech Ltd is scheduled for January 21, 2026...." }, { "title": "Indo US Bio-Tech Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-3789655", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndoUSBioTechLt_mojoScore_3789655.png", "date": "2026-01-12 10:10:52", "description": "Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook." }, { "title": "Indo US Bio-Tech Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-3774474", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndoUSBioTechLt_mojoScore_3774474.png", "date": "2025-12-30 08:56:23", "description": "Indo US Bio-Tech Ltd has seen its investment rating upgraded from Sell to Hold as of 29 Dec 2025, reflecting a nuanced improvement in technical indicators, valuation metrics, and financial trends despite recent flat quarterly performance. This shift highlights a cautious optimism among analysts amid ongoing market challenges and the company’s attractive long-term fundamentals." }, { "title": "Indo US Bio-Tech Faces Market Challenges Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-downgraded-to-sell-amid-weak-technicals-and-flat-financials-3767855", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndoUSBioTech_mojoScore_3767855.png", "date": "2025-12-24 08:23:20", "description": "Indo US Bio-Tech, a player in the Other Agricultural Products sector, is currently navigating a complex market environment marked by subdued financial results, shifting technical indicators, and valuation contrasts. Recent assessment changes reflect a nuanced view of the company’s prospects amid broader market dynamics." } ], "total": 214, "sid": "1002989", "stock_news_url": "https://www.marketsmojo.com/news/indo-us-bio-tech-1002989" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Indo US Bio-Tech Ltd has declared <strong>2%</strong> dividend, ex-date: 03 Dec 24", "dt": "2024-12-03", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Indo US Bio-Tech Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Aug 23", "dt": "2023-08-29", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Jan 19: Stock hits 52-week low at Rs.110.20 amid market pressure

Jan 20: New 52-week low at Rs.107.25; Mojo Grade downgraded to Sell

Jan 21: Further 52-week low at Rs.105.40 despite intraday gains

Jan 22: Reports sharp quarterly financial decline; stock rebounds +3.03%

Jan 23: Stock closes week at Rs.118.30, up 2.42% on the day

Week Open

...

Read full news article

Indo US Bio-Tech Ltd Reports Sharp Decline in Quarterly Financials Amid Negative Trend Shift

2026-01-22 08:00:17

Indo US Bio-Tech Ltd has reported a significant downturn in its latest quarterly financial performance, marking a shift from a previously flat to a negative financial trend. The company’s December 2025 quarter results reveal contraction across key metrics including revenue, profitability, and earnings per share, signalling challenges ahead for this player in the Other Agricultural Products sector.

Read full news article

Indo US Bio-Tech Ltd Falls to 52-Week Low Amidst Continued Underperformance

2026-01-20 11:46:35

Indo US Bio-Tech Ltd’s stock declined sharply to a new 52-week low of Rs.109.7 today, marking a significant drop amid a challenging market environment and subdued financial performance. The stock’s fall contrasts with the broader market’s mixed movements, highlighting company-specific pressures.

Read full news article

Indo US Bio-Tech Downgraded to Sell Amid Technical Weakness and Flat Financials

2026-01-20 08:30:06

Indo US Bio-Tech Ltd, a player in the Other Agricultural Products sector, has seen its investment rating downgraded from Hold to Sell as of 19 Jan 2026. This shift reflects deteriorating technical indicators, flat recent financial performance, and a challenging near-term outlook despite some strong long-term fundamentals. The company’s Mojo Score has declined to 47.0, signalling caution for investors amid a 3.8% drop in share price on the downgrade day.

Read full news article

Indo US Bio-Tech Ltd Falls to 52-Week Low Amidst Continued Market Pressure

2026-01-19 15:41:07

Indo US Bio-Tech Ltd, a player in the Other Agricultural Products sector, touched a fresh 52-week low of Rs.110.15 today, marking a significant decline amid broader market weakness and sector underperformance. The stock’s fall reflects ongoing pressures despite some underlying financial strengths.

Read full news article

When is the next results date for Indo US Bio-Tech Ltd?

2026-01-13 23:16:11

The next results date for Indo US Bio-Tech Ltd is scheduled for January 21, 2026....

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-01-12 10:10:52

Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Indo US Bio-Tech Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2025-12-30 08:56:23

Indo US Bio-Tech Ltd has seen its investment rating upgraded from Sell to Hold as of 29 Dec 2025, reflecting a nuanced improvement in technical indicators, valuation metrics, and financial trends despite recent flat quarterly performance. This shift highlights a cautious optimism among analysts amid ongoing market challenges and the company’s attractive long-term fundamentals.

Read full news article

Indo US Bio-Tech Faces Market Challenges Amid Mixed Financial and Technical Signals

2025-12-24 08:23:20

Indo US Bio-Tech, a player in the Other Agricultural Products sector, is currently navigating a complex market environment marked by subdued financial results, shifting technical indicators, and valuation contrasts. Recent assessment changes reflect a nuanced view of the company’s prospects amid broader market dynamics.

Read full news article